Precision medicine has the potential to transform healthcare, offering personalized treatments tailored to each patient’s unique genetic, environmental, and lifestyle factors. However, achieving this vision on a global scale requires tackling key barriers—from data integration to access and affordability. At LifeNome Inc., we’re proud to host the Precision Health Summit, powered by 1BusinessWorld , where Gabriele Allegri, VP of Global Commercial Precision Medicine at Johnson & Johnson Innovative Medicine, shared his roadmap for making precision medicine accessible to patients worldwide.
At the summit, Allegri highlighted ten critical areas: building robust clinical evidence, streamlining fragmented data systems, and advancing molecular guidance in clinical settings. He stressed the need for new reimbursement models tailored to precision medicine’s unique demands and advocated for public-private partnerships to foster cross-sector collaboration. Addressing economic challenges and enhancing patient trust are equally crucial, as privacy concerns around genetic testing remain a barrier for many patients. Allegri also underscored the importance of interdisciplinary collaboration, bringing together specialists across fields to deliver integrated, patient-centered care.
Allegri envisions a future where precision medicine is the standard, accessible to all patients regardless of background. Through shared commitment and collective action, this shift in healthcare is within reach, paving the way for more effective, personalized treatments.
#PrecisionHealth #PersonalizedMedicine #HealthTech #HealthData #PrecisionHealthSummit
https://lnkd.in/ekenRi8f
Ali Mostashari, Ph.D Stelios Hatzakis
CEO & Co-Founder | Claimable Inc.
2moYou've got to wear the Han Solo vest when you present.